Kaposi's sarcoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
* The staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness. | * The staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness. | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Factors}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Good Risk (Stage 0)}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Poor Risk (Stage 1)}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
Tumor (T) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Confined to skin and lymph nodes | |||
* Minimal oral lesions (non-nodular kaposi's sarcoma confined to the palate) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Tumor-associated edema or ulceration | |||
* Extensive oral lesions present | |||
* Gastrointestinal lesions present | |||
* Kaposi sarcoma present in other non-nodal viscera | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center | | |||
Immune system (I) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* CD4 cell count ≥ 200/µL | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* CD4 cell count < 200/µL | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center | | |||
Systemic illness (S) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* No history of opportunistic infection or thrush | |||
* No “B” symptoms | |||
* Karnofsky performance status score ≥ 70 | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Positive history of opportunistic infection or thrush | |||
* “B” symptoms present | |||
* Karnofsky performance status score < 70 | |||
|} | |||
==References== | ==References== | ||
Revision as of 15:53, 20 January 2016
|
Kaposi's sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Kaposi's sarcoma staging On the Web |
|
American Roentgen Ray Society Images of Kaposi's sarcoma staging |
|
Risk calculators and risk factors for Kaposi's sarcoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
There is no established system for the staging of Kaposi's sarcoma among immune competent patients. However, the staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness.[1][2][3][4][5]
Staging
- There is no established system for the staging of Kaposi's sarcoma among immune competent patients.
- The staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, immune status, and the presence of any systemic illness.
| Factors | Good Risk (Stage 0) | Poor Risk (Stage 1) |
|---|---|---|
|
Tumor (T) |
|
|
|
Immune system (I) |
|
|
|
Systemic illness (S) |
|
|
References
- ↑ Kaposi Sarcoma Treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq#section/_15 Accessed on January, 20 2015
- ↑ Krown SE, Metroka C, Wernz JC (1989). "Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 7 (9): 1201–7. PMID 2671281.
- ↑ Krown SE, Testa MA, Huang J (1997). "AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 15 (9): 3085–92. PMID 9294471.
- ↑ Sarcoma- Kaposi Guide. Cancer.Net (2015) http://www.cancer.net/cancer-types/sarcoma-kaposi/risk-factors-and-prevention Accessed on January, 20 2015
- ↑ How is Kaposi sarcoma staged? American Cancer Association (2015) http://www.cancer.org/cancer/kaposisarcoma/detailedguide/kaposi-sarcoma-staging Accessed on January, 20 2016